Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009.
Saved in:
| Title: | Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009. |
|---|---|
| Authors: | Regidor D; Department of Biostatistics & Epidemiology, Amgen, Inc, Thousand Oaks, CA 91320, USA., McClellan WM, Kewalramani R, Sharma A, Bradbury BD |
| Source: | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2011 May; Vol. 26 (5), pp. 1583-91. Date of Electronic Publication: 2010 Sep 22. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2385 (Electronic) Linking ISSN: 09310509 NLM ISO Abbreviation: Nephrol Dial Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
